When:
November 16, 2019 @ 7:00 am – 3:00 pm
2019-11-16T07:00:00-05:00
2019-11-16T15:00:00-05:00
Where:
Renaissance Nashville Hotel
611 Commerce St
Nashville, TN 37203
USA

Oncology Nurses Quality Improvement Series

Please join us for this free CNE event!

Saturday, November 16, 2019

Renaissance Nashville Hotel
611 Commerce Street
Nashville, TN 37203
Meeting Room: Wedgewood
Exhibit/Meals: Germantown 4
Breakfast: 7:00 AM – 8:00 AM
Meeting: 8:00 AM – 3:00 PM

5 CNE Credits

FACULTY
Michael R. Grunwald, MD
Chief, Leukemia Division
Department of Hematologic Oncology and Blood Disorders
Levine Cancer Institute, Atrium Health
Charlotte, NC

David S. Ettinger, MD, FACP, FCCP
Alex Grass Professor of Oncology
The Sidney Kimmel Comprehensive
Cancer Center at Johns Hopkins
Baltimore, MD

Kathy Madden, RN, MSN, FNP-BC, AOCNP, APHN
NYU Melanoma Program I Clinical Cancer Center
New York, NY

Tanguy Seiwert, MD
Director, Head and Neck Oncology Disease Group
Johns Hopkins Medicine
Baltimore, MD

Andrea Fehl, CRNP, AOCNP
Women’s Cancer Center
Magee-Women’s Hospital
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania

LIVE EVENT REGISTRATION
To pre-register for the live event, please visit https://oncologynurse.wpengine.com or www.ONQ-TN.com or by calling 207-406-4248

PRESENTATION TRACKS
Acute Myeloid Leukemia
Considerations for Oncology Nurses—Individualizing the Management of Acute Myeloid Leukemia: Genomics, Targeted Therapeutic Options, and Treatment Sequencing
Michael R. Grunwald, MD

NSCLC
From the Nurses’ Perspective: Immuno-Oncology Treatment Options Shared Decision-Making in Advanced NSCLC
David S. Ettinger, MD, FACP, FCCP

Melanoma
The Importance of the Nurse—Patient Interaction in Optimizing Treatment of Advanced Melanoma
Kathy Madden, RN, MSN, FNP-BC, AOCNP, APHN

Head and Neck
The Oncology Nurses’ Role in the Management of Immunotherapy for Head and Neck Cancer
Tanguy Y. Seiwert, MD

Breast Cancer
The Use and Implementation of Targeted Therapy for Early HER2-positive Breast Cancer: An Expanding Role for Nurse
Andrea Fehl, CRNP, AOCNP

TARGET AUDIENCE
Oncology certified nurses and oncologists

ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 5.0 AMA Category 1 Credit(s)TM.
Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION
Purpose:This program would be beneficial for nurses involved in the care of oncology patients.
Credits:5 ANCC Contact Hour(s)

CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 5.0 contact hour(s) of continuing nursing education of RNs and APNs.

ONCC RECERTIFICATION POINTS
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com